Background: This study aims to quantify by intravital microscopy the microhemodynamic response after extracorporeal shock wave application (ESWA) to the physiologic microcirculation of the mouse dorsal skinfold chamber.
INTRODUCTION
Extracorporeal shock wave application (ESWA) is increasingly investigated for the management of acute and chronic inflammatory pathologies of muscle, nerve, and skin [1] [2] [3] . Shock waves are usually electrohydraulically induced biphasic transient pressure changes characterized by a fast positive and a following slower negative wave. After reaching a tissue boundary, the acoustic energy is transformed into mechanical energy, whereby its biological effect is directly proportional to the difference in impedance of the two adjacent media. One of the indirect biological effects is the cavitation phenomenon (CP). CP is thought to occur during the second phase of a shock wave, when the negative pressure induces the formation of ultrastructural vesicles, which by collapsing cause a multidirectional asymmetrical fluid stream within the tissue [4] . The successful treatment of bony non-union when using ESWA was thought to be related to CP by causing microfractures and stimulating healing [5] . However, molecular biological investigations in rat femurs exposed to ESW demonstrated the stimulation of bone-marrow stromal growth and its differentiation towards osteoprogenitors through the induction of tumor growth factor (TGF-b1) [6] . Similar findings in a segmental bone defect model indicated a predominant chemotactic and
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mitogen role of vascular endothelial growth factor (VEGF-A) in the recruitment and differentiation of mesenchymal stem cells after ESWA [7] . Enhanced cellular proliferation and regeneration by proliferating cell nuclear antibody (PCNA) and insulin-like growth factor (IGF-I) were demonstrated after ESWA of rat Achilles tendons [8] . Furthermore ESWA has been shown to exert a significant synergistic growth inhibitory effect on tumour cells when applied in combination with chemotherapeutic agents [9, 10] , which was explained by CP-induced permeabilization of cellular membranes and intercellular connections [11, 12] . Recent investigations revealed decreased leukocytic infiltration and suppression of tumour necrosis factor a (TNF-a) in critically perfused random skin flaps after ESWA [13] . Only few studies report the biological effect of ESWA on the circulatory system. Increased local perfusion after low dose ESWA in patients suffering from advanced ischemic limb disease coincided with the clinical improvement of the patient's pain-free walking distance [14] . Similarly, ESWA improved regional myocardial blood flow in a porcine model of chronic cardiac ischemia as measured by coloured microspheres [15, 16] . This effect could be reproduced in humans with end-stage coronary artery disease, whereby increased myocardial perfusion persisted for at least 12 mo [17] . In another study of cardiac ESWA, enhanced coronary angiogenesis was associated with reduced angina pectoris in patients with severe coronary artery disease, whereby no adverse effects were noted [18] . Accordingly, improved local perfusion was suggested after ESWA-associated reduction of necrosis using an epigastric skin flap model and a dorsal skin random flap model, respectively [13, [19] [20] [21] . The exposition of human umbilical vascular endothelial cells (HUVECs) to low dose ESWA revealed a significant upregulation of VEGF m-RNA protein, indicating a direct vascular effect [22] . Induction of neovascularisation by ESWA could histologically be confirmed in Achilles tendons of dogs and rabbits [23, 24] . In another study using adductor muscles in rats, stroma cell-derived factor 1 (SDF-1) together with VEGF were increased following ESWA, indicating the up-regulation of chemoattractants targeting circulating endothelial progenitor cells to promote angio-and vasculogenesis [24] . To date, there is no study exploring the in vivo effect of ESWA on the microcirculation. The present study investigates the microvascular response to ESWA in the mouse dorsal skinfold chamber.
MATERIALS AND METHODS

Animals
Experiments were performed according to the guidelines of the University Hospital of Zurich. The study protocol was approved by the Federal Veterinary Office of Zurich. A total of 33 mice (C57BL/6 J; 12-24 wk; 2-26 g body weight (BW); Harlan, Switzerland) were included in the study. The animals were housed in single cages at a room temperature (RT) of 22 C and at a relative humidity of 60%-65% with a 12 h/12 h light-dark cycle. The animals were allowed free access to tap water and standard laboratory chow.
Experimental Model
The dorsal skinfold chamber in mice was used for intravital microscopy as previously described [25, 26] . Briefly, mice were anesthetized intraperitoneally with a mixture of 90 mg/kg BW ketamine hydrochloride (Ketavet; Q4 Parke Davis; Freiburg, Germany) and 25 mg/kg BW xylazine hydrochloride (Rompun; Bayer, Leverkusen, Germany), and two symmetric titanium frames were implanted to sandwich the extended double layer of the skin. One layer was removed in a 15 mm diameter circular area. The remaining layer consisting of epidermis, subcutaneous tissue, and striated skin muscle was covered with a glass coverslip, incorporated in one of the titanium frames. Animals tolerated the chamber well and showed no signs of discomfort or changes in sleeping and feeding habits. A recovery period of 3 d was allowed before the experiment was started.
Extracorporeal Shock Wave Application (ESWA)
The anesthetized animals were placed in left lateral position. ESWA to the chamber tissue was carried out using an electrohydraulic shock wave source (dermaPACE; Sanuwave, Switzerland). An ultrasound transmission gel (Parker Laboratories Inc Q5 ., NJ) was applied as contact medium to the applicator, which was gently placed directly on the dorsal skinfold chamber tissue after removing the cover glass. ESWA was performed with a dose of 500 or 1000 pulses, with an energy flux rate of 0.08 mJ/mm 2 , and at a frequency of 4 Hz. Shamprepared skinfold chambers were treated identically during 2 min, however no ESWA was performed.
Intravital Fluorescence Microscopy
For in vivo microscopic analysis of the microcirculation, the anesthetized mice were placed in left lateral position on a Plexiglas stage. Microhemodynamic measurements were performed using an epiillumination intravital microscope (Leica DM/LM; Leica Microsystems, Wetzlar, Germany) attached to a blue (450-490/ > 520 nm), a green (530-560/ > 580 nm), and an ultraviolet (330-390/ > 430 nm excitation/emission wavelength) filter system. Microscopic images were displayed on a television screen (Trinitron PVM-20N5E; Sony, Q6 UK), and recorded on video (50 Hz; Panasonic AG-7350-SVHS; Tokyo, Japan) for subsequent off-line analysis. The preparation was observed visually with a water immersion objective 320 with a numerical aperture of 0.50, which resulted in total optical magnification of 3800 on the video monitor. Animals received a tail vein injection of 0.05 mL fluoresceinisothiocyanate (FITC)-dextran (MW 150,000; 50 mg/mL saline), (Sigma-Aldrich, Buchs, Switzerland) for vascular contrast enhancement, and 0.05 mL rhodamine 6 G (0.1 mg/mL saline), (Sigma-Aldrich, Buchs, Switzerland) for leukocyte staining in vivo. This allowed for quantitative analysis of microvascular perfusion and leukocyte-endothelial cell interaction using long distance objectives (magnification: 34, numerical aperture: 0.16; 310, 0.30; 320, 0.32; Zeiss Q7 ). The microvessels were classified according to physiological and anatomical features into conduit arterioles, capillaries and small collecting venules.
Quantitative Microcirculation Analysis
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capillary fields, and five to seven draining postcapillary venules. Video printouts were made during videography and initially marked to indicate the exact localization for measurements of vessel diameter and red blood cell (RBC)-velocity. Using a computer-assisted image analysis system (CapImage; Zeintl Software; Heidelberg, Germany), functional capillary density (FCD) was assessed as the length of RBC-perfused capillaries per observation area (cm/cm 2 ) [27] . Diameters were measured in micrometers (mm) perpendicularly to the vessel path. Centerline RBC-velocity was analyzed by computer-assistance using the line-shift method (CapImage). Volumetric blood flow was calculated from diameter (d) and RBC-velocity (v) by Q ¼ p * (d/2) 2 * v/1.6 (pl/s), where 1.6 represents the Baker-Wayland factor to correct for the parabolic velocity profile in microvessels with diameters > 20 mm [28] . Rolling leukocytes were defined as cells moving with a velocity less than two-fifth of the centerline velocity, and are given as number of cells per minute passing a reference point within the microvessel. The number of permanent adherent leukocytes (defined as cells that adhered to the venular vessel wall over a period of 30 s) was evaluated as number of cells per square millimeter endothelial surface (calculated from diameter and length of the vessel segment studied, assuming cylindrical geometry) [26] .
Experimental Protocol
The study comprised three different groups. Sham animals (n ¼ 6) underwent chamber preparation without ESWA. One ESWA group (n ¼ 6) received 500 pulses at 0.08 mJ/mm 2 , the other ESWA group (n ¼ 6) received 1000 pulses. Sham-treated animals (n ¼ 6) received 0 pulses. Repetitive intravital microscopic observations were performed at baseline (BL) before ESWA and at 1, 2, 6 h as well as 1, 2, and 3 d after ESWA. Sham-treated animals were studied at corresponding time points and served as controls. At the end of the experiments, the animals were euthanized by injection of an overdose of the anaesthetic. Five additional animals of each group were killed 1 d after treatment and used for immunohistochemical studies.
Immunohistochemistry
Tissues were evaluated for caspase-3 (casp-3), PCNA, von Willebrand factor (vWF), and endothelial nitric oxide synthase (eNOS) by immunohistochemistry. Tissue samples were obtained from the middle of the chamber tissue 1 d after ESWA. They were fixed in 4% paraformaldehyde, washed in phosphate buffered saline (PBS), stored in 70% ethanol, and finally embedded in paraffin blocks. For analysis of expression of casp-3, PCNA, vWF, and eNOS, 4 mm sections were incubated with a primary rabbit anti-casp-3 antibody (1:500; Abcam), a primary rabbit anti-PCNA antibody (1:500; Abcam), a primary rabbit anti-factor 8-(vWF) antibody (1:1000; Dako, A 0082), and a primary rabbit anti-eNOS antibody (1:20; Assay Design, 905-386) over night at RT. As secondary antibody the anti-rabbit EnVision (DakoCytomation EnVisionþSystem Labelled Polymer-HRP Anti-Rabbit K4003; Zug, Switzerland) was used for 30 min at RT and AEC (Aminoethyl Carbazole Substrate Kit; Zymed Laboratories, San Francisco, CA) was applied as chromogen. Between each step, the slides were washed with PBS (pH 7.4) and in each trial, positive and negative control slides were included. Casp-3 and PCNA were examined by the average of positive cells counted in 10 randomly selected visual fields at a magnification of 320. Sebaceous glands and hair follicles were identified and excluded from the cell counts because of their consistently high apoptosis rate. VWF was examined by the average of positive endothelial cells counted in 10 randomly selected visual fields at a magnification of 320. The intensity of the staining reactions of eNOS in endothelial cells was evaluated by a Zeiss Axioplan 2 imaging system (Carl Zeiss, Oberkochen, Germany) at a magnification of 3100 using a semiquantitative score (graded as 0 ¼ no, 1 ¼ weak, 2 ¼ moderate, and 3 ¼ strong staining).
Statistical Analysis
All values are expressed as means 6 standard deviation (SD). For comparison between individual time points, ANOVA for repeated measures was performed, which was followed by the appropriate post-hoc test, including the correction of the a-error according to Bonferroni probabilities. ANOVA for comparison of multiple groups was performed to compare treatment groups with sham, followed by Student-Newman-Keuls test for appropriate post-hoc analysis (Sigma-Stat; Jandel, San Rafael, CA). A P value < 0.05 was taken to indicate statistically significant differences.
RESULTS
Analysis of arteriolar and venular diameters, RBCvelocities, and blood flows revealed comparable values at BL in all groups studied (Table 1) . ESWA did not significantly affect diameters and flow conditions in arterioles and venules during the entire phase of observation (data not shown). Also, venular wall shear rates were not affected by ESWA (data not shown).
Analysis of FCD as well as capillary diameter, RBCvelocity, and blood flow revealed comparable values at BL in all groups studied (Table 1) . However, neither 500 nor 1000 pulses of ESWA resulted in significant changes of capillary diameters, RBC-velocity, and blood flow during the postinterventional period of observation (data not shown). Strikingly, ESWA provoked a significant increase (P < 0.05) of FCD compared with BL and sham-operated animals, which lasted during the whole period of observation ( Fig. 1) . When animals were treated with 1000 pulses, increased FCD was Values are mean6 SD. Note that there were no significant differences between the groups. sw, shock waves. 256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320   321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373  374  375  376  377  378  379  380  381  382  383 384 385
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even more pronounced compared with 500 pulses only (P < 0.05, not significant at 6 h, 2 and 3d).
Analysis of venular leukocyte rolling and adherence revealed comparable values at BL in all groups studied (Table 1) . ESWA provoked an increase (P < 0.05) of leukocyte rolling, which was most pronounced 24 h after application of 1000 pulses (w3.5-fold) and then gradually decreased to values comparable to those observed at BL ( Fig. 2A) . When animals were treated with 1000 pulses, increased leukocyte rolling was even more pronounced compared with 500 pulses only (P < 0.05, not significant at 1 h and 3 d). In line with this, leukocyte adherence was increased (P < 0.05) maximally w2-fold 24 h after application of 1000 pulses and then gradually decreased to values comparable to those observed at BL (Fig. 2B) .
The numbers of interstitial casp-3 and PCNA positive cells at d 1 following ESWA are demonstrated in Fig. 3 . ESWA enhanced casp-3 expression w3.5-fold (P < 0.05 versus sham) when animals were treated with 500 pulses and w4.5-fold (P < 0.05 versus other groups) after 1000 pulses. PCNA expression was enhanced w9.5fold (P < 0.05 versus sham) when animals were treated with 500 pulses and w14-fold (P < 0.05 versus other groups) after 1000 pulses.
The number of vWF positive endothelial cells at d 1 following ESWA is demonstrated in Fig. 4A . Expression of vWF was distinct in the endoluminal aspects of endothelial cells in untreated animals. Five hundred pulses increased the number of vWF positive endothelial cells w14-fold (P < 0.05 versus sham), whereas 1000 pulses led to a w11-fold increased cell count (P < 0.05 versus sham).
Expression of eNOS was distinct in the endoluminal aspects of endothelial cells in untreated animals.
Following ESWA, however, the entire cytoplasm showed a w3-fold increase in eNOS expression (P < 0.05 versus sham) with no significant difference between 500 and 1000 pulses (Fig. 4B) .
Representative photographs of immunohistochemically stained paraffin sections are shown in Fig. 5 .
DISCUSSION
Herein we report for the first time that ESWA to the microcirculation of striated muscle is capable of increasing capillary patency starting as early as 1 h after application. This effect is most likely conveyed by increased availability of nitric oxide (NO) within the stimulated endothelium, since eNOS has been found to be up-regulated. ESWA also provoked a slight microvascular inflammatory tissue response lasting as long as 3 d. Furthermore, elevated expression of casp-3 
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indicates apoptotic effects, and increased production of PCNA within the tissue confirms previous findings suggesting that shock wave treatment may entail proliferative effects.
The first description of the therapeutic use of highenergy shock waves in 1980 revolutionized the treatment of urinary calculi [29] . Since then, numerous studies have demonstrated favorable biological responses during fracture healing as well as for the treatment of inflammatory soft tissue pathologies of tendons and joints [1, 2, 3, [30] [31] [32] [33] [34] [35] . However, the mechanisms by which the target tissues respond to ESWA are not understood. Davis et al. showed in a mouse model of full-thickness burn that ESWT causes significant anti-inflammatory effects associated with a decrease of proinflammatory cytokine synthesis and reduced leukocyte recruitment 1 h after the injury [36] . Inflammatory response in this study, however, was quantified based on in vitro methods such as RT-PCR screening of 188 candidate genes and immunohistology of leukocyte and macrophage infiltration. In contrast to this, our study, which investigates the effects of ESWA on the microcirculation for the first time in an in vivo setting, clearly revealed, even if slight, a pro-inflammatory response with a significant increase in rolling and sticking leukocytes to the endothelial lining. This tissue reaction started immediately after ESWA at an energy rate of 0.08 mJ/mm 2 with 500 and 1000 pulses at a frequency of 4 Hz and slowly declined over a time period of 3 d.
On the other hand, beneficial properties of ESWA could be observed in parallel, namely the significant increase in FCD of 20% after 1 h with a maximal increase of 40% after 24 h in the 1000 pulse group. This effect was also reproducible, however to a lesser extent, after the application of 500 pulses, and was maintained for 3 d in both groups. The rapid increase in FCD most likely was caused by the recruitment of capillaries. Capillary recruitment, a well-known phenomenon, is observed during hypoxia, exercise, or neural stimulation [37] [38] [39] . Increased local production of endothelialderived NO has been presumed as a possible mechanism, since blocking of NOS enzymes inhibited microvascular recruitment [40] . In our study, eNOS was significantly up-regulated 1 d after ESWA. The observation of increased eNOS levels after ESWA is in line with findings of other researchers [41] [42] [43] . In addition, we observed a significantly increased expression of vWF within the endothelial lining. VWF is a strong marker of endothelial activation and is intensively expressed, for instance, during acute coronary syndromes [44, 45] . Thus, it can be hypothesized that the mechanical force applied through ESWA activates the endothelium causing upregulation of resident enzymes and factors. 516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580   581  582  583  584  585  586  587  588  589  590  591  592 593 594
Next to the acute effects on the vascular system caused by ESWA, angiogenesis has been presumed to play a role in long-term effects. De Sanctis et al. treated patients suffering from advanced ischemic limb disease with low dose shock waves with energy levels ranging from 0.03 to 0.5 mJ/mm 2 , and found a significant increase in local perfusion as measured by laser Doppler flux measurements [14] . These measurements coincided with the clinical improvement of the patient's pain-free walking distance. The effects of shock waves on distal ischemic skin flap necrosis were examined in rats using different skin flap models [13, [19] [20] [21] . All studies showed a significant increase in mean percentage of the flap survival area after ESWA and can be seen as an indicator of improved local perfusion.
VEGF is a well known mitogen, which not only acts as a vasodilator and increases endothelial permeability but also plays a significant role during angiogenesis [46] . Gutersohn et al. exposed HUVECs to low dose shock waves [22] . Quantification of VEGF m-RNA 36 h after treatment revealed a significant up-regulation of the protein. Wang et al. used the Achilles tendon of dogs to investigate the proposed induction of neovascularisation after ESWA histologically. Indeed, they found a considerable increase of the number of newly formed vessels and muscularized vessels at 4 and 8 wk after treatment [47] . Meirer et al. employed the rat epigastric skin flap model not only to compare the effectiveness of shock wave treatment to an untreated control group, but also to the intravenous treatment with adenovirus-mediated VEGF or TGF-b [48, 49] . Neither gene therapy with TGF-b nor VEGF were as effective in increasing the percentage of flap survival compared with ESWA. Kuo , and endothelial nitric oxide synthase (eNOS) in cross sections of the mouse dorsal skinfold 1 d after extracorporeal shock wave application (ESWA) with 500 pulses or 1000 pulses at an energy flux rate of 0.08 mJ/mm 2 and a frequency of 4 Hz compared with normal expression in sham-operated animals. Note the strong expression of PCNA in the interstitium (arrowheads) and vWF as well as eNOS in endothelial cells (arrows) following ESWA. Note also a marked accumulation of casp-3 positive apoptotic cells in the tissue (stars) after 500 and 1000 pulses. (Scale bar ¼ 100 mm).
in VEGF and PCNA expression in shock wave treated random flaps in rats [13] . In our study, we found an up-regulation of PCNA, which is an early marker for cell proliferation. However, no microvascular angiogenic signs, such as the formation of buds or sprouts from the microvasculature, were observed in the first 3 d after ESWA. Elsewhere, when applying models of incisional wound healing, these angiogenic changes originating from capillaries and venules are clearly visible as early at 2 d after the incision in the dorsal skinfold chamber. Thus, it can be deduced that a potential angioproliferative response to ESWT may be triggered as early as 1 h after shock wave application, as indicated by the substantially increased level of PCNA. However, neither vasculogenesis nor angiogenesis were initialized within the first 3 d. Assuming normoxia in our model and taking into consideration that hypoxia is the most important trigger to induce angiogenesis in noncancerous tissue, further studies are necessary to investigate whether ESWA is capable of rapidly forming new vessels in critically perfused tissues to counteract hypoxic tissue damage. Stojadinovic et al. described an increased expression of pro-angiogenic genes applying cDNA super arrays after full-thickness skin grafting starting at 6 h after ESWA resulting in an increased vessel density in immunohistological sections [51] . Again, merely in vitro methods were applied lacking the possibility to assess the formation and patency of newly formed vessels in vivo.
The increase in cleaved casp-3 expression 1 h after ESWA in our study implies a proapoptotic effect [52] . In line with our investigations, beneficial structural changes in the rat penis after ESWA treatment of Peyronie's disease were associated with a higher apoptotic index [53] . However, a study investigating the influence of ESWA during urethral stone therapy on ovarian tissue, apoptosis did not reveal an increased apoptotic cell death [54] . Findings in a segmental bone defect model indicated the increase in TGF-b and also VEGF-A played a chemotactic and mitogenic role in the recruitment and differentiation of mesenchymal stem cells [7] . In a further study, the authors could also show a significant induction of mitogen-activated protein kinase activity regulators in cell growth, differentiation, and apoptosis, which lasted up to 42 d after ESWA [55] .
It can be concluded that ESWA leads to an immediate, slight inflammatory tissue response in vivo, which is paralleled by a pronounced and long-lasting, most probably NO-related capillary recruitment starting as early as 1 h after ESWA. The application of this mechanical energy most likely activates the vascular endothelium by the up-regulation of resident enzymes and factors such as eNOS and vWF. Even if prolifera-tion indicator PCNA was found to be up-regulated, angiogenesis phenomenons within the microvasculature were not observed during the first 3 d. The findings of the herein presented study warrant further research to study the effects of high pressure acoustic pulses on the microvasculature. 776  777  778  779  780  781  782  783  784  785  786  787  788  789  790  791  792  793  794  795  796  797  798  799  800  801  802  803  804  805  806  807  808  809  810  811  812  813  814  815  816  817  818  819  820  821  822  823  824  825  826  827  828  829  830  831  832  833  834  835  836  837  838  839  840   841  842  843  844  845  846  847  848  849  850  851  852  853  854  855  856  857  858  859  860  861  862  863  864  865  866  867  868  869  870  871  872  873  874  875  876  877  878  879  880  881  882  883  884  885  886  887  888  889  890  891  892  893  894  895  896  897  898  899  900  901  902  903  904  905 
